Cargando…

Utilization Trend of Parenteral Antidiabetic Drugs in Type 2 Diabetic Patients Covered by Iran Health Insurance Organization from 2011 to 2030

BACKGROUND: Exploring and analyzing the cost of medicines is an important tool for their management and planning. This study aims to analyze the utilization and costs of parenteral anti-diabetic medications during the past decade and predict the future trend of these medications from 2021 to 2031 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shojaee, Ali, Akbari Sari, Ali, Farzadfar, Farshad, Davari, Majid, Daroudi, Rajabali, Shajari Pour Mousavi, Sayyed Masoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362211/ https://www.ncbi.nlm.nih.gov/pubmed/37484727 http://dx.doi.org/10.18502/ijph.v52i5.12725

Ejemplares similares

National geographical pattern of COVID-19 hospitalization, case fatalities, and associated factors in patients covered by Iran Health Insurance Organization
por: Damiri, Soheila, et al.
Publicado: (2022)

Application of discrete choice experiments to estimate value of life: a national study protocol in Iran
por: Mirzaee, Negar, et al.
Publicado: (2021)

The challenges of strategic purchasing of healthcare services in Iran Health Insurance Organization: a qualitative study
por: Gorji, Hasan Abolghasem, et al.
Publicado: (2018)

Direct Costs of Hypertension Treatment in Iran
por: Zamandi, Mahmoud, et al.
Publicado: (2023)

Public preferences regarding the priority setting criteria of health interventions for budget allocation: results of a survey of Iranian adults
por: Darvishi, Ali, et al.
Publicado: (2022)

Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds
por: Daroudi, Rajabali, et al.
Publicado: (2021)

Public Preferences and Willingness to Pay for a COVID-19 Vaccine in Iran: A Discrete Choice Experiment
por: Darrudi, Alireza, et al.
Publicado: (2022)

The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-effectiveness Analysis of IraPEN Program in the General Population of Iran
por: Mokhtari, Mehdi, et al.
Publicado: (2022)

Extent, nature and hospital costs of fireworks-related injuries during the Wednesday Eve Festival in Iran
por: Alinia, Siros, et al.
Publicado: (2013)

Life and health satisfaction in the adult population of Iran
por: Daroudi, Rajabali, et al.
Publicado: (2016)

Correction to: Health-related quality of life measured using the EQ-5D-5 L: population norms for the capital of Iran
por: Emrani, Zahra, et al.
Publicado: (2020)

Health-related quality of life measured using the EQ-5D–5 L: population norms for the capital of Iran
por: Emrani, Zahra, et al.
Publicado: (2020)

Payment systems for dialysis and their effects: a scoping review
por: Emrani, Zahra, et al.
Publicado: (2023)

The Economic Burden of Breast Cancer in Iran
por: DAROUDI, Rajabali, et al.
Publicado: (2015)

The impact of common chronic conditions on health-related quality of life: a general population survey in Iran using EQ-5D-5L
por: Akbari Sari, Ali, et al.
Publicado: (2021)

Health-Related Quality of Life in Osteoporosis Patients with and without Fractures in Tehran, Iran
por: Rajabi, Marziyeh, et al.
Publicado: (2023)

A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma
por: Daroudi, Rajabali, et al.
Publicado: (2022)

Direct costs of common osteoporotic fractures (Hip, Vertebral and Forearm) in Iran
por: Rajabi, Marziyeh, et al.
Publicado: (2021)

Development of attributes and levels of mental health insurance services using a discrete choice experiment
por: Rahmani, Hojjat, et al.
Publicado: (2023)

Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
por: Darvishi, Ali, et al.
Publicado: (2023)

Premature mortality of gastrointestinal cancer in Iran: trends and projections 2001–2030
por: Shadmani, Fatemeh Khosravi, et al.
Publicado: (2020)

Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer
por: Nahvijou, Azin, et al.
Publicado: (2016)

Labiaplasty and Insurance: To Cover or Not to Cover?
por: Rowley, Mallory, et al.
Publicado: (2022)

Cost-utility analysis of Cryoballoon ablation versus Radiofrequency ablation in the treatment of paroxysmal atrial fibrillation in Iran
por: Darvishi, Ali, et al.
Publicado: (2022)

Economic burden of colorectal cancer in Iran in 2012
por: Vahdatimanesh, Zahra, et al.
Publicado: (2017)

Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys
por: Ebrahimi, Hedyeh, et al.
Publicado: (2023)

Predicting Iran’s achievement to Sustainable Development Goal 3.2: A systematic analysis of neonatal mortality with scenario-based projections to 2030
por: Ebrahimi, Narges, et al.
Publicado: (2023)

Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on JNC-IV and 2017 ACC/AHA Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (TLGS)
por: Saatchi, Mohammad, et al.
Publicado: (2020)

Non-Parenteral Medications for Procedural Sedation in Children- A Narrative: Review Article
por: FALLAH, Razieh, et al.
Publicado: (2015)

Eliciting Preferences for Health Insurance in Iran Using Discrete Choice Experiment Analysis
por: Kazemi Karyani, Ali, et al.
Publicado: (2019)

A Conceptual Framework for Evaluation of Public Health and Primary Care System Performance in Iran
por: Jahanmehr, Nader, et al.
Publicado: (2015)

Performance evaluation and ranking of regional primary health care and public health Systems in Iran
por: Rashidian, Arash, et al.
Publicado: (2021)

Gaussian process forecasts Pseudogymnoascus destructans will cover coterminous United States by 2030
por: Wiens, Ashton M., et al.
Publicado: (2022)

Willingness to Pay for Complementary Health Care Insurance in Iran
por: NOSRATNEJAD, Shirin, et al.
Publicado: (2017)

Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran
por: RASHIDIAN, Hamideh, et al.
Publicado: (2018)

Determinants of healthcare expenditures in Iran: evidence from a time series analysis
por: Rezaei, Satar, et al.
Publicado: (2016)

A cost-effectiveness analysis of risk-based intervention for prevention of cardiovascular diseases in IraPEN program: A modeling study
por: Jamshidi, Amirparviz, et al.
Publicado: (2023)

INSURANCE COVER AGAINST LOSS OF EARNINGS
por: Association du personnel
Publicado: (2009)

Willingness To Pay for Social Health Insurance in Iran
por: Nosratnejad, Shirin, et al.
Publicado: (2014)

Developing attributes and levels for a discrete choice experiment on basic health insurance in Iran
por: Kazemi Karyani, Ali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m9e4j8hc1qg5efta7gkccm10t7